SCORTEN accurately predicts mortality among toxic epidermal necrolysis patients treated in a burn center

Journal of Burn Care and Research

Volumn 29, Issue 1, 2008, Pages 141-146

  Cartotto, Rob ^a   Mayich, Mike ^a   Nickerson, Duncan ^a   Gomez, Manuel ^a  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BIOBRANE; IMMUNOGLOBULIN;

ADULT; ARTICLE; BURN; CALIBRATION; CHI SQUARE TEST; CONFIDENCE INTERVAL; DEATH; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; ENTERIC FEEDING; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SCORING SYSTEM; SCORTEN; STATISTICAL SIGNIFICANCE; TOXIC EPIDERMAL NECROLYSIS;

ADULT; AGE FACTORS; BURN UNITS; BURNS; EPIDERMAL NECROLYSIS, TOXIC; FEMALE; HEALTH STATUS INDICATORS; HUMANS; MALE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SICKNESS IMPACT PROFILE;

EID: 38049050747     PISSN: 1559047X     EISSN: 15590488     Source Type: Journal    
DOI: 10.1097/BCR.0b013e31815f3865     Document Type: Article

References (14)

1. Lyell A. Toxic Epidermal Necrolysis: an eruption resembling scalding of the skin. Br J Dermatol 1956;68:355-61.
2. Roujeau JC, Kelly JP. Severe adverse cutaneous reactions to drugs. New Engl J Med 1994;331:1272-85.
3. Wolkenstein P, Revuz J. Toxic epidermal necrolysis. Dermatol Clinics 2000;18:485-495.
4. Palmieri TL, Greenhalgh DG, et al. A multicenter review of toxic epidermal necrolysis treated in U.S. burn centers at the end of the twentieth century. J Burn Care Rehabil 2002;23:87-96.
5. Bastuji-Garin S, Fouchard N, Bertocchi M, Roujeau JC, Revuz J, Wolkenstein P. SCORTEN: a severity of illness score for toxic epidermal necrolysis. J Invest Dermatol 2000;115:149-153.
6. Imahara SD, Holmes JH, Heimbach DM, et al. SCORTEN overestimates mortality in the setting of a standardized treatment protocol. J Burn Care Res 2006;27:270-275.
7. Cartotto R, Fish J. Exfoliative disorders of the skin. In: Mathes S, editor. Plastic surgery. Vol 1. Philadelphia: Saunders Elsevier; 2006: p 793-810.
8. Shortt R, Gomez M, Mittman N, Cartotto R. Intravenous immunoglobin does not improve outcome in toxic epidermal necrolysis. J Burn Care Rehabil 2004;25:246-255.
9. Prins C, Kerdel F, Padilla RS, et al. Treatment of toxic epidermal necrolysis with high dose intravenous immunoglobulins:multicenter retrospective analysis of 48 consecutive cases. Arch Dermatol 2003;139:26-32.
10. Pagano M, Gauvreau K. Principles of biostatistics. Belmont, CA: Duxbury Inc. 1993; p 128-130.
11. Lemeshow S, Hosmer DW. A review of goodness of fit statistics for use in the development of logistic regression models. Am J Epidemiol 1982;115:92-106.
12. Trent JT, Kirsner RS, Romanelli P, Kerdel FA. Use of SCORTEN to accurately predict mortality in patients with toxic epidermal necrolysis in the United States. Arch Dermatol 2004;140:890-892.
13. Marshall T, Haegerty A. Scoring with SCORTEN. Arch Dermatol 2003;139:1215 (letter).
14. Guegan S, Bastuji-Garin S, Poszepczynska-Guigne E, Roujeau JC, Revuz J. Performance of the SCORTEN during the first five days of hospitalization to predict the prognosis of epidermal necrolysis. J Investig Dermatol 2006;126:272-276.